Article Details

AI-driven Biotech Company Begins Phase I Trial of Mesothelioma Drug

Retrieved on: 2025-01-23 15:30:31

Tags for this article:

Click the tags to see associated articles and topics

AI-driven Biotech Company Begins Phase I Trial of Mesothelioma Drug. View article details on hiswai:

Excerpt

Biotechnology company Insilico Medicine has announced the dosing of the first patient in a global Phase I trial of its newest mesothelioma drug ...

Article found on: mesothelioma.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up